Tan SY, Feng X, Cheng LKW, Wu AR
A mole that changes in color, size, or shape on the thigh, shin, or knee should also be checked
In addition to having a 20% lower risk overall of major cardiac events, such as heart attack, stroke, or cardiovascular death, participants who took Wegovy had a 28% reduction in heart attacks (for those already taking heart medications, such as statins, to reduce cholesterol), a 7% decrease in non-fatal strokes, and a 15% drop in cardiovascular-related deaths
This foundational benefit makes metformin an ideal partner for newer GLP-1 receptor agonists like semaglutide
10.1038/nrm3012 Nat
In This Article Understanding GLP-1 Medications and Cancer Concerns What Current Research Shows About Thyroid Cancer Risk Pancreatic Cancer Risk: Separating Fact from Fear Potential Cancer-Protective Benefits Common Side Effects vs Serious Concerns Who Should Avoid GLP-1 Medications Making Informed Decisions About GLP-1 Treatment Accessing GLP-1 Medications Affordably The Bottom Line on GLP-1 Cancer Risk References Understanding GLP-1 Medications and Cancer Concerns GLP-1 receptor agonists work by mimicking a hormone your body naturally makes after eating
